000 01207 a2200313 4500
005 20250515123109.0
264 0 _c20080710
008 200807s 0 0 eng d
022 _a1389-5575
024 7 _a10.2174/138955708784567430
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZiedan, Noha I
245 0 0 _aThe development of pro-apoptotic cancer therapeutics.
_h[electronic resource]
260 _bMini reviews in medicinal chemistry
_cJun 2008
300 _a711-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aApoptosis
650 0 4 _aEnergy Metabolism
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMitochondria
_xdrug effects
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xantagonists & inhibitors
650 0 4 _aX-Linked Inhibitor of Apoptosis Protein
_xantagonists & inhibitors
700 1 _aKadri, Hachemi
700 1 _aWestwell, Andrew D
773 0 _tMini reviews in medicinal chemistry
_gvol. 8
_gno. 7
_gp. 711-8
856 4 0 _uhttps://doi.org/10.2174/138955708784567430
_zAvailable from publisher's website
999 _c18023564
_d18023564